Waldenström Lifetime Achievement Award
Named for Jan Waldenström, a pioneer in treating blood cancers, the Waldenström Lifetime Achievement Award has been given by the IMS at each International Myeloma Workshop since 1989. This award is given to outstanding researchers in recognition of their long term contributions to the myeloma field.
Recipient Profile
Thierry Facon, MD, is Professor of Haematology in the Department of Haematology, Lille University Hospital, Lille, France, a position he has held since 2000.
Professor Facon is currently President of the French Society of Hematology and was President of the Intergroupe Francophone du Myélome (IFM) between 2003 and 2006. Professor Facon is a member of the French Academy of Medicine and has presented at several international congresses, including the Plenary session at the annual meeting of the American Society of Clinical Oncology (ASCO) in 2006, the Plenary sessions at the annual meeting of the American Society of Hematology (ASH) in 2013 and 2018 the Educational Session of European Haematology Association (EHA) in 2008 and 2014, and the Educational session of ASH in 2015 and 2018. He co-organized the XIIIth International Myeloma Workshop (IMW) in Paris in 2011, and is a member of the American Society of Hematology (ASH), the European Hematology Asoociation (EHA), the International Myeloma Working Group (IMWG), and the International Myeloma Society (IMS). He is a founder member and administrator of the Fondation Française pour la Recherche contre le Myélome et les Gammapathies (FFRMG) under the aegis of the Fondation de France
He has presented the “Pierre Stryckmans Memorial Lecture” of the Belgian Hematological Society in 2015 and received the Joseph Michaeli Award from Weill Cornell Medicine, New York USA for his contributions to the treatment of Myeloma Research in 2017 and the International Myeloma Foundation Robert A. Kyle Life Time Achievement Award in 2020. Professor Facon is author and co-author of a number of articles and has published his work in various prestigious international journals including, as first or senior author, The Lancet and The New England Journal of Medicine.
Past Recipients
- 1989 – D. Bergsagel – deceased (April 25, 1925 – October 20, 2007)
- 1991 – R. Kyle
- 1993 – S. Salmon – deceased (May 8, 1936-October 6, 1999)
- 1995 – M. Potter – deceased (February 27, 1924 – June 18, 2013)
- 1997 – R. Alexanian
- 1999 – B. Barlogie
- 2001 – H. Mellstedt
- 2003 – K. Anderson
- 2005 – J-L Harousseau
- 2007 – J. San Miguel
- 2009 – B. Durie
- 2011 – W. M. Kuehl
- 2013 – N. Munshi
- 2015 – M. Attal
- 2017 – M. A. Dimopoulos
- 2019 – G. Merlini
- 2021 – S. Vincent Rajkumar
- 2022 – P. Sonneveld
- 2023 – S. Jagannath
- 2024 – T. Facon
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
